Clinical Trials Directory

Trials / Completed

CompletedNCT00766805

Endoscopic Variceal Ligation (EVL)+ Drugs Versus Endoscopic Variceal Ligation (EVL) Alone For Secondary Prophylaxis

Endoscopic Variceal Ligation Plus Propranolol And Isosorbide Mononitrate Versus Endoscopic Variceal Ligation Alone For Secondary Prophylaxis Of Variceal Bleeding: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
177 (actual)
Sponsor
Govind Ballabh Pant Hospital · Other Government
Sex
All
Age
8 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Background: Both endoscopic variceal ligation (EVL) and propranolol are valuable methods for secondary prophylaxis of variceal bleeding. Addition of ISMN to propranolol improves the efficacy of drug therapy. It is hypothesized that a combination of EVL and portal pressure reducing drugs should significantly be better than EVL alone. Patients and Methods: Patients with history of variceal bleed were randomized to EVL plus drugs (propranolol and ISMN) or EVL alone. EVL was repeated every 3-4 weeks until variceal eradication. Propranolol dose was adjusted to reduce the resting heart rate to 55 bpm. Dose of ISMN was 40 mg/d. Primary end points were rebleed or death. Secondary end points included complications of portal hypertension and the development of serious adverse effects to therapy.

Conditions

Interventions

TypeNameDescription
DRUGEVL + Propranolol + Isosorbide 5 mononitrateTreatment was started with propranolol at a dose of 40 mg twice a day. The heart rate and blood pressure were checked after 12 to 24 hours. The dose of propranolol was increased at increments of 20 to 40 mg per day until the patient achieved a heart rate of 55 bpm, or a maximum dose of 320 mg/day was achieved.ISMN was added at a dose of 10 mg twice a day. The dose was escalated at increments of 10-20 mg/day till a maximum dose of 40 mg/day was reached.
OTHEREVL alone

Timeline

Start date
2002-10-01
Primary completion
2006-12-01
Completion
2007-06-01
First posted
2008-10-06
Last updated
2008-10-06

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT00766805. Inclusion in this directory is not an endorsement.